| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.27 | 0.08 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.08 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.22 | 0.08 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.095 | 0.08 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 0.08 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.089 | 0.09 |